3Shape appoints new Chief Financial Officer
COPENHAGEN, Denmark, May 5, 2026 /PRNewswire/ -- 3Shape today announced the appointment of Stefan Kratzer as Chief Financial Officer effective 5 May. He will join the Senior Leadership Team and report directly to CEO Jacob Paulsen. The appointment ensures strong leadership continuity, with an experienced successor stepping into the role. "As we enter the next phase of our journey, it...
Samsung Biologics Listed on Dow Jones Best-in-Class World Index for Fifth Consecutive Year
Marks five consecutive years of inclusion, reflecting continued progress in ESG management and execution Recognition highlights proactive alignment with evolving expectations from global stakeholders INCHEON, South Korea, May 5, 2026 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing organization (CDMO), announced that it has been included...
New World Lupus Federation Global Survey Finds 58% Know Very Little or Nothing About Lupus
Low familiarity and ongoing misconceptions underscore the need for increased education and broader visibility, building on more than a decade of progress WASHINGTON, May 5, 2026 /PRNewswire/ -- The World Lupus Federation (WLF) today released new global survey results on public awareness, attitudes, and perceptions of lupus ahead of World Lupus Day (May...
Tech-Enabled, Lightweight Aesthetics and Green Sustainability: A Close Look at Health & Recreation Category of 139th Canton Fair
GUANGZHOU, China, May 5, 2026 /PRNewswire/ -- From surgical robotics to compact massage furniture blending into modern interiors, and eco‑friendly personal‑care products leading a greener shift, a wave of innovation defined by high technology, lightweight design, and sustainability is reshaping the Health & Recreation category at the 139th Canton Fair. Standing out from...
Blueprint for a Lifetime: Hill’s ‘World of the Kitten’ Report Supports Veterinary Teams & Pet Parents in Navigating the Critical First Year
Groundbreaking report highlights kittenhood as a critical one-year developmental window, showcasing new research on gut health, proactive veterinary care and shelter support. OVERLAND PARK, Kan., May 5, 2026 /PRNewswire/ -- As a global leader in science-led nutrition, Hill's Pet Nutrition (Hill's), is continuing to set a new standard for feline health with the...
Senhwa Biosciences Launches Global Study, Targeting Breakthrough in Hard-to-Treat Cancers with CX-5461 and Tislelizumab Combination
TAIPEI and SAN DIEGO, May 5, 2026 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a clinical-stage biopharmaceutical company today announced the initiation of a global, multi-center clinical trial. The Company has also submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA), marking a key milestone...
IHH Healthcare Unifies Enterprise Systems with Oracle Fusion Cloud Applications to Strengthen Care Delivery Across Markets
Multinational integrated healthcare provider plans to consolidate multiple enterprise systems onto single AI-enabled cloud platform to boost productivity, cost efficiency and patient-centred care SINGAPORE, May 5, 2026 /PRNewswire/ -- IHH Healthcare (IHH), one of the world's largest integrated healthcare providers, has selected Oracle Fusion Cloud Applications across its enterprise finance, human resource (HR)...
Cleveland Clinic, RIKEN, and IBM Model a 12,635-Atom Protein – the Largest Known to Be Simulated with Quantum Computers
Milestone simulation of biologically meaningful molecules expands quantum-centric supercomputing's role as a scientific tool YORKTOWN HEIGHTS, N.Y. and CLEVELAND, May 5, 2026 /PRNewswire/ -- Scientists at Cleveland Clinic, RIKEN, and IBM (NYSE: IBM) have used IBM quantum computers and two of the world's most powerful supercomputers to simulate protein complexes spanning up to 12,635 atoms. These are the largest-known simulations...
Cellenkos Announces FDA Clearance of Investigational New Drug (IND) Application for Phase 1b/ 2a Trial of CK0802 in Steroid-Refractory Graft-versus-Host Disease (GVHD)
Multicenter, open-label study will evaluate the safety and preliminary efficacy of CK0802, a first-in-class, off-the-shelf Treg therapy, in patients with steroid-refractory GVHD HOUSTON, May 5, 2026 /PRNewswire/ -- Cellenkos®, Inc., a clinical stage biotechnology company, pioneering allogeneic, tissue-targeted regulatory T cell (Treg) therapies, today announced that the U.S. Food and Drug...
New Publication Demonstrates TLX250-Px (Zircaix®) Potential in Diagnosing Kidney Cancers Beyond ccRCC
MELBOURNE, Australia and INDIANAPOLIS, Ind., May 5, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces the publication of a new independent analysis of Phase 3 ZIRCON trial data in European Urology, demonstrating that TLX250‑Px (Zircaix®, 89Zr-girentuximab) PET/CT imaging may be highly predictive of renal malignancy across all subtypes,...
